FDA 执法报告 D-0182-2027:Advagen Pharma 酒石酸美托洛尔片因混入外来片剂或胶囊列为 II 类召回
FDA drug enforcement D-0182-2027: Advagen Pharma Limited — Presence of Foreign Tablets/Capsules
FDA 于 2026-11-11 发布的执法报告将 Advagen Pharma Limited 的酒石酸美托洛尔片 USP 50 mg 召回列为 II 类,原因为产品中存在外来片剂或胶囊。
记录列出 II 类召回的批次、数量与分销范围,便于核对同一 event_id 下的其他产品记录。
FDA drug recall enforcement report — D-0182-2027
Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "50 Millstone Rd Bldg 200",
"address_2": "",
"center_classification_date": "20261110",
"city": "East Windsor",
"classification": "Class II",
"code_info": "Batch#: 2611C065A1: Expiry: 05/2028",
"country": "United States",
"distribution_pattern": "U.S. Nationwide",
"event_id": "100234",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA200981"
],
"brand_name": [
"METOPROLOL TARTRATE"
],
"generic_name": [
"METOPROLOL TARTRATE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Advagen Pharma Ltd"
],
"package_ndc": [
"72888-208-01",
"72888-208-05",
"72888-208-00",
"72888-208-02",
"72888-209-01",
"72888-209-05",
"72888-210-01",
"72888-210-05",
"72888-210-00",
"72888-210-02",
"72888-211-01",
"72888-211-05",
"72888-212-01",
"72888-212-05",
"72888-212-00"
],
"product_ndc": [
"72888-208",
"72888-209",
"72888-210",
"72888-211",
"72888-212"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"ORAL"
],
"rxcui": [
"866511",
"866514",
"866924",
"1606347",
"1606349"
],
"spl_id": [
"5ddfcd4c-5388-13b9-e063-6394a90aea69"
],
"spl_set_id": [
"3ecff825-34ea-4535-b935-627bf2c13d93"
],
"substance_name": [
"METOPROLOL TARTRATE"
],
"unii": [
"W5S57Y3A5L"
],
"upc": [
"0372888212005",
"0372888209050",
"0372888208008",
"0372888209012",
"0372888211053",
"0372888212012",
"0372888212050",
"0372888211015",
"0372888210056",
"0372888208015",
"0372888210001",
"0372888210018",
"0372888208053"
]
},
"postal_code": "08520-1415",
"product_description": "Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.",
"product_quantity": "3684 bottles",
"product_type": "Drugs",
"reason_for_recall": "Presence of Foreign Tablets/Capsules",
"recall_initiation_date": "20261027",
"recall_number": "D-0182-2027",
"recalling_firm": "Advagen Pharma Limited",
"report_date": "20261111",
"state": "NJ",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov